Example: Heart Attack

Search clinical trials for: Octreotide

Total 253 results

NCT04353193

Not yet recruiting

Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

Conditions: Liver Cirrhosis Portal
NCT04296149

Completed

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

Conditions: Neuroendocrine Tumors
NCT04281680

Completed

Impact of Pasireotide on Postoperative Pancreatic Fistulas Following Distal Resections

Conditions: Surgical Complications
NCT04140409

Terminated

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation

Conditions: Neuroendocrine Tumors; Carcinoid Syndrome
NCT04129255

Active, not recruiting

Octreotide LAR in the Induction of Immunologic Response in NENs Patients

Conditions: Neuroendocrine Tumors
NCT04125836

Recruiting

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Conditions: Acromegaly
NCT04076462

Recruiting

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Conditions: Acromegaly
NCT04048707

Not yet recruiting

Angiotensin 2 for Hepatorenal Syndrome

Conditions: Hepatorenal Syndrome; Cirrhosis; Kidney Failure, Acute
NCT04029428

Recruiting

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Conditions: Neuroendocrine Tumors
NCT04027348

Recruiting

Palliative Management of Inoperable Malignant Bowel Obstruction

Conditions: Malignant Bowel Obstruction
NCT04028323

Recruiting

Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)

Conditions: Renal Function Disorder; Acute Variceal Bleeding
NCT03972488

Recruiting

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

Conditions: Gastro-enteropancreatic Neuroendocrine Tumor
NCT03891849

Recruiting

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

Conditions: Haemorrhagic Shock; Variceal Hemorrhage
NCT03883776

Completed

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Conditions: Neuroendocrine Tumors
NCT03879694

Recruiting

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Conditions: Lung Atypical Carcinoid Tumor; Lung Typical Carcinoid Tumor; Metastatic Pancreatic Neuroendocrine Tumor
NCT03846180

Completed

Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage

Conditions: Variceal Hemorrhage; Cirrhosis, Liver; Kidney Injury
NCT03812939

Recruiting

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Conditions: Gastric NET
NCT03798912

Completed

A First-in-Human Study of Enteral Drug Delivery Device

Conditions: Healthy Volunteers
NCT03791736

Terminated

Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation

Conditions: Breast Cancer; Lymphocele
NCT03792555

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)

Conditions: Acromegaly
NCT03756116

Recruiting

Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide

Conditions: Post-ERCP Acute Pancreatitis; Epinephrine
NCT03741517

Recruiting

Biomarker Study of Pancreatic Neuroendocrine Tumours

Conditions: Pancreatic Neuroendocrine Tumor
NCT03734627

Enrolling by invitation

Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery

Conditions: Esophageal Cancer; Nutrition Disorders; Appetite Disorders; Dumping Syndrome; Delayed Gastric Emptying; Surgery
NCT03724409

Recruiting

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

Conditions: Neuroendocrine Tumors
NCT03624517

Recruiting

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Conditions: Esophageal Varices; Liver Cirrhoses; Bleeding Esophageal Varices; Upper Gastrointestinal Bleeding
NCT03571594

Terminated

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Conditions: Acromegaly
NCT03541447

Recruiting

Tolvaptan-Octreotide LAR Combination in ADPKD

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT03520569

Recruiting

Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

Conditions: Vascular Stiffness; Insulin Sensitivity
NCT03511768

Recruiting

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Conditions: Neuroendocrine Neoplasm
NCT03455322

Unknown status

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Conditions: Renal Impairment in Hepatorenal Syndrome
NCT03398941

Unknown status

The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial

Conditions: Pancreatic Diseases
NCT03377660

Enrolling by invitation

Resection of the Esophagus and Subsequent Weight Loss: How Clinical Treatment Affects Appetitive Behaviour and Food Reward

Conditions: Esophageal Cancer; Weight Gain; Eating Behavior; Food Reward
NCT03347760

Not yet recruiting

Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis

Conditions: Myocarditis
NCT03289741

Recruiting

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Conditions: Neuroendocrine Tumors
NCT03273712

Recruiting

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)

Conditions: Neuroendocrine Tumors; Meningioma; Neuroblastoma; Medulloblastoma
NCT03252353

Active, not recruiting

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly

Conditions: Acromegaly
NCT03197012

Completed

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Conditions: Neuroendocrine Tumor
NCT03179995

Active, not recruiting

Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy

Conditions: Major Liver Resection
NCT03158090

Recruiting

The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

Conditions: Acromegaly
NCT03112694

Completed

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Conditions: Neuroendocrine Tumors
NCT03103009

Recruiting

Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia

Conditions: Hyperinsulinemic Hypoglycemia; Post Gastrointestinal Tract Surgery Hypoglycaemia
NCT03061604

Completed

RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding

Conditions: Variceal Hemorrhage
NCT03057509

Withdrawn

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Conditions: Small Bowel Carcinoid Tumor
NCT03044977

Active, not recruiting

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Conditions: Neuroendocrine Tumor, Malignant; Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting
NCT03031535

Completed

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Conditions: Healthy Volunteer Study
NCT03017690

Completed

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Conditions: Gastroenteropancreatic Neuroendocrine Tumor
NCT03013387

Withdrawn

Dosimetry Guided PRRT With 90Y-DOTATOC

Conditions: Neuroendrocrine Tumors; Meningioma; Neuroblastoma; Medulloblastoma
NCT03001349

Active, not recruiting

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Conditions: Meningioma; Metastatic Well Differentiated Neuroendocrine Neoplasm; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Neoplasm; Somatostatin Positive Neoplastic Cells Present; Von Hippel-Lindau Syndrome
NCT03000946

Active, not recruiting

Prevention of Postoperative Pancreatic Fistula by Somatostatin

Conditions: Pancreatic Surgery
NCT02977897

Unknown status

Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide

Conditions: Diarrhea; Immunosuppression